Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Alain Castaigne"'
Autor:
Jean-François Bergmann, Michel Andrejak, Jean-Pierre Bader, Marion Bamberger, Pascal Bilbault, Régis Bordet, Agnès Brouard, Anne Burstin, Alain Castaigne, Anne Castot, Alain Coulomb, Muriel Dahan, Frédéric DeBels, Corinne Duguay, Nathalie Dumarcet, Pierre Fender, Christian Funck Brentano, Isa-belle Giri, Pascale Jolliet, Murielle Jousselon Pautrot, Florence Leclerc, Patricia Le Gonidec, Patricia Maillere, François Meyer, Thierry Moreau Defarges, Olivier Obrecht, Gilles Paintaud, Nicole Petitcollot, Marc Samama, Julia Sauterey, Pierre Schiavi, Philippe Tcheng, Patrick Villani, Monique Weber, Nadine Weisslinger Darmon, Myriam Zylberman
Publikováno v:
Therapies. 63:267-273
Resume Le bon usage des medicaments peut etre defini simplement comme l’utilisation du bon medicament, a la bonne dose, pendant la duree necessaire, pour un patient donne qui le tolere correctement. Il est impossible, etant donne le nombre de medic
Autor:
Alain Castaigne, Yves-Dominique Henry, Carole Omnes, Alain Puech, Chrystel Jouan-Flahault, Nathalie Billon, Myriam Rosilio, Catherine Lassale
Publikováno v:
Therapies. 62:393-415
Resume Le Leem (Les Entreprises du Medicament) a realise un etat des lieux des besoins medicaux non ou mal couverts en 2006 en France pour 12 pathologies retenues comme priorites de sante publique dans le cadre de la loi du 9 aout 2004. Alliees aux p
Autor:
Alain Castaigne
Publikováno v:
Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2005:19-25
Autor:
Milton Packer, Terry L. Holcslaw, Michal Tendera, Alain Castaigne, Armin Scherhag, Michael B. Fowler, Hugo A. Katus, Jean-Lucien Rouleau, Ellen B. Roecker, Henry Krum, Paul Mohacsi, Andrew J.S. Coats
Publikováno v:
Journal of the American College of Cardiology. 43:1423-1429
OBJECTIVES We sought to evaluate the influence of pretreatment systolic blood pressure (SBP) on the efficacy and safety of carvedilol in patients with chronic heart failure (CHF). BACKGROUND Although beta-blockers reduce the risk of death in CHF, the
Autor:
Paul Mohacsi, Hugo A. Katus, Michal Tendera, Andrew J.S. Coats, Milton Packer, Jean L. Rouleau, Ildiko Amann-Zalan, Silke Hoersch, J Trawinski, Alain Castaigne, Henry Krum, Franz Hartmann, Michael B. Fowler
Publikováno v:
European Journal of Heart Failure. 6:343-350
Background: Neither profiles nor prognostic value of cardiac N-terminal proBNP (NT-proBNP) have been prospectively evaluated in a sufficient number of patients with severe chronic heart failure (CHF) treated with carvedilol or placebo. Methods: Basel
Autor:
Peter W. de Leeuw, Talma Rosental, Gilbert Wagener, Christopher R. Palmer, Luis M. Ruilope, Alain Castaigne, G. Mancia, Morris J. Brown
Publikováno v:
Blood Pressure. 13:310-315
Aims: This study tested the effects on cardiovascular outcomes of treatments based on nifedipine gastrointestinal therapeutic system (GITS) compared with the diuretic combination co-amilozide in a pre-specified subset of patients with isolated systol
Autor:
Morris J. Brown, Christopher R. Palmer, Alain Castaigne, G. Mancia, Luis M. Ruilope, Talma Rosenthal, P. W. De Leeuw
Publikováno v:
European Heart Journal Supplements. 3:B20-B26
Background We compared the effects of a long-acting calcium-channel blocker with a thiazide-amiloride combination on cardiovascular mortality and morbidity in patients with additional cardiovascular risk factors. The primary objective was to demonstr
Autor:
Peter W. de Leeuw, Giuseppe Mancia, Talma Rosenthal, Morris J. Brown, Luis M. Ruilope, Alain Castaigne, Christopher R. Palmer
Publikováno v:
The Lancet. 356:366-372
Summary Background The efficacy of antihypertensive drugs newer than diuretics and β-blockers has not been established. We compared the effects of the calcium-channel blocker nifedipine once daily with the diuretic combination co-amilozide on cardio
Publikováno v:
PharmacoEconomics. 17:603-609
Objective: We compared the estimated costs of coronary interventions from our hospital’s cost accounting system with data from the French Diagnosis Related Group (DRG) cost database, taking the perspective of our hospital. Design: Cost data on hosp
Autor:
G. Mancia, Talma Rosenthal, Luis M. Ruilope, Alain Castaigne, P. W. De Leeuw, Morris J. Brown, Christopher R. Palmer
Publikováno v:
Hypertension. 35:1038-1042
Abstract —The aim of our investigation was to determine whether the presence of additional risk factors or type of hypertension (diastolic or isolated systolic) influences blood pressure (BP) response to treatment. The International Nifedipine GITS